Carpenter Technology Corporation engages in the manufacture, fabrication, and distribution of specialty metals in the United States, Europe, the Asia Pacific, Mexico, Canada, and internationally. It operates in two segments, Specialty Alloys Operations and Performance Engineered Products. The company offers specialty alloys, including titanium alloys, powder metals, stainless steels, alloy steels, and tool steels, as well as additives, and metal powders and parts. It serves to aerospace, defense, medical, transportation, energy, industrial, and consumer markets. The company was founded in 1889 and is headquartered in Philadelphia, Pennsylvania.

Carpenter Technology Corporation

Shares of Corsair ($CRSR) are surging today after the computer hardware company announced its move into AI infrastructure with the launch of CORSAI...

Corsair (CRSR) Stock Surges as It Expands into AI Infrastructure

J.P. Morgan analyst Bill Peterson maintained a Buy rating on Carpenter Technology yesterday and set a price target of $470.00. Peterson covers the ...

J.P. Morgan Remains a Buy on Carpenter Technology (CRS)

The latest update is out from Crest Nicholson Holdings ( ($GB:CRST) ). Crest Nicholson has disclosed share transactions involving its senior leader...

Crest Nicholson Executives Acquire Shares Under Incentive Plan

Piper Sandler analyst Biren Amin maintained a Buy rating on Aclaris Therapeutics today and set a price target of $11.00. According to TipRanks, Ami...

Aclaris Therapeutics (ACRS) Gets a Buy from Piper Sandler

Guggenheim analyst Seamus Fernandez reiterated a Buy rating on Aclaris Therapeutics today and set a price target of $12.00. According to TipRanks, ...

Guggenheim Keeps Their Buy Rating on Aclaris Therapeutics (ACRS)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Medline (MDLN), Aclaris Therapeutics (ACRS) and Alkermes (ALKS). ...

Analysts Offer Insights on Healthcare Companies: Medline (MDLN), Aclaris Therapeutics (ACRS) and Alkermes (ALKS)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Silence Therapeutics (SLN), Aclaris Therapeutics (AC...

Analysts’ Top Healthcare Picks: Silence Therapeutics (SLN), Aclaris Therapeutics (ACRS)

Oppenheimer analyst Jeff Jones reiterated a Buy rating on Aclaris Therapeutics today and set a price target of $10.00. Jones covers the Healthcare ...

Aclaris Therapeutics (ACRS) Gets a Buy from Oppenheimer

Craig-Hallum analyst Adam Vogel maintained a Buy rating on Aclaris Therapeutics today and set a price target of $10.00. Vogel covers the Healthcare...

Aclaris Therapeutics (ACRS) Gets a Buy from Craig-Hallum

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Dexcom (DXCM), Ironwood Pharma (IRWD) and Crispr Therapeutics AG ...

Analysts Conflicted on These Healthcare Names: Dexcom (DXCM), Ironwood Pharma (IRWD) and Crispr Therapeutics AG (CRSP)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BioMarin Pharmaceutical (BMRN) and Crispr Therapeuti...

Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN) and Crispr Therapeutics AG (CRSP)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on GeneDx Holdings (WGS) and Crispr Therapeutics AG (CRSP). GeneDx H...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: GeneDx Holdings (WGS) and Crispr Therapeutics AG (CRSP)

In a report released yesterday, Geulah Livshits from Chardan Capital reiterated a Buy rating on Crispr Therapeutics AG, with a price target of $76....

Chardan Capital Remains a Buy on Crispr Therapeutics AG (CRSP)

Analysts have been eager to weigh in on the Industrial Goods sector with new ratings on Adt (ADT) and Carpenter Technology (CRS). Adt (ADT) In a re...

Analysts’ Opinions Are Mixed on These Industrial Goods Stocks: Adt (ADT) and Carpenter Technology (CRS)

In a report released today, Samuel McKinney from KeyBanc maintained a Buy rating on Carpenter Technology, with a price target of $459.00. According...

KeyBanc Sticks to Their Buy Rating for Carpenter Technology (CRS)

Crest Nicholson Holdings ( ($GB:CRST) ) has issued an announcement. Crest Nicholson Holdings plc has confirmed that its issued share capital now co...

Crest Nicholson Updates Share Capital and Voting Rights After Minor New Issue

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Indivior (INDV), Aclaris Therapeutics (ACRS) and Com...

Analysts Are Bullish on Top Healthcare Stocks: Indivior (INDV), Aclaris Therapeutics (ACRS)

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on NXP Semiconductors (NXPI), Celestica (CLS) and Cor...

Analysts’ Opinions Are Mixed on These Technology Stocks: NXP Semiconductors (NXPI), Celestica (CLS) and Corsair Gaming (CRSR)

Caprice Resources Ltd. ( ($AU:CRS) ) has issued an update. Corella Resources has agreed to acquire a 75 per cent interest in the Chobe Project in W...

Corella Resources Secures Majority Stake in West Arunta Critical Minerals Project

An announcement from Caprice Resources Ltd. ( ($AU:CRS) ) is now available. Caprice Resources has agreed to sell a 75% interest in its West Arunta ...

Current Quarter	$3	Next Quarter	$2.82
Current Year	$10.49	Next Year	$12.28
QoQ Growth	-6.0%	YoY Growth	+17.1%
3Y EPS CAGR	+1.1%	Target Price	$456.13
Consensus	Buy	Upside	+0.5%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CRS	$453.69	+4.51%	741.99K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CRS	$453.69	+4.5%	741.99K
3
4
5
6

CRS

CRS

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Carpenter Technology Corporation Data in Excel

Get Carpenter Technology Corporation Data in Excel